The Solid Tumor Program at Children's Hospital of Philadelphia (CHOP) combines the expertise of specialists in related disciplines through an intensely collaborative treatment approach. CHOP's Cancer Center is one of the few pediatric cancer programs in the country with a team like this, dedicated to solid tumors.
A core group of attending pediatric oncologists works to treat children with a wide variety of solid tumors, including newly diagnosed neuroblastoma.
The core group develops comprehensive treatment plans that may include surgery, chemotherapy and radiation therapy. Our oncologists regularly collaborate with pediatric orthopaedic surgeons through our Bone and Soft Tissue Tumor Program to care for children with musculoskeletal tumors like Ewing sarcoma, rhabdomyosarcoma and osteosarcoma. When appropriate, limb-sparing (also known as limb-salvage) and reconstructive surgery are offered by our pediatric orthopaedic surgeons. CHOP surgeons regularly perform these complex surgeries, and are constantly working to improve outcomes for children with the most difficult-to-treat tumors.
Patients who receive solid tumor treatment at CHOP typically see members of the core group during each Hospital visit so they can build a relationship with their caregivers, and their caregivers can get to know them well.
In addition to the individual attention patients receive from their primary oncologists, they benefit from the collective expertise of the entire Solid Tumor treatment group. The full treatment group remains actively involved in the oversight of every patient's care, discussing patients' needs and treatment on a regular basis.